Citation

Selloni A, Bhatia G, Ranganathan M, De Aquino JP. J. Dual Diagn. 2022; 18(2): 81-91.

Copyright

(Copyright © 2022, Informa - Taylor and Francis Group)

DOI

10.1080/15504263.2022.2053264

PMID

35430960

PMCID

PMC9794455

Abstract

OBJECTIVE: Cannabis use (CU) is common among persons with bipolar disorder (BD). Evidence suggests that CU is associated with poorer outcomes among persons with BD; however, these findings remain inconsistent. The present exploratory study aims to examine clinical, functional, and cognitive correlates of CU among persons with BD.

METHODS: U.S. veterans with BD type I who participated in a large-scale, nationwide study were categorized into four groups: current CU, past CU, past other drug use, and no drug use. Bivariate analyses, univariate analyses of covariance, and Levene's Test for Equality of Variance were used to compare groups on clinical, cognitive, and functional measures.

RESULTS: Of 254 (84.6% male) veterans with BD type I included in the analyses, 13 (5.1%) had current CU, 37 (14.5%) past CU, 77 (30.3%) past other drug use, and 127 (50%) reported no drug use. BD with CU was associated with post-traumatic stress disorder (PTSD) and experiencing lifetime suicidal ideation. Notably, current CU was associated with higher working memory performance, compared to both past CU and no drug use. Likewise, current CU was associated with higher functional capacity, compared to past CU as well as no drug use.

CONCLUSIONS: These findings contribute to the growing literature on the complex effects of cannabis on BD. As the commercialization and legalization of cannabis increases, further research in this area is warranted to quantify posed risks to this population, and thereby guide clinical decision-making.

Language: en

Keywords

Humans; Female; Male; Substance-Related Disorders; Suicidal Ideation; Cognition; Bipolar disorder; Cannabis; veterans; Analgesics; Veterans; Stress Disorders, Post-Traumatic; Bipolar Disorder; cannabis use; multimodal correlates